34 related articles for article (PubMed ID: 9400990)
1. Cell cycle-dependent regulation of p185neu: a relationship between disruption of this regulation and transformation.
Kiyokawa N; Yan DH; Brown ME; Hung MC
Proc Natl Acad Sci U S A; 1995 Feb; 92(4):1092-6. PubMed ID: 7862640
[TBL] [Abstract][Full Text] [Related]
2. Absence of autophosphorylation site Y882 in the p185neu oncogene product correlates with a reduction of transforming potential.
Zhang HT; O'Rourke DM; Zhao H; Murali R; Mikami Y; Davis JG; Greene MI; Qian X
Oncogene; 1998 Jun; 16(22):2835-42. PubMed ID: 9671404
[TBL] [Abstract][Full Text] [Related]
3. Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein.
Weiner DB; Kokai Y; Wada T; Cohen JA; Williams WV; Greene MI
Oncogene; 1989 Oct; 4(10):1175-83. PubMed ID: 2571965
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
Arita Y; Buffolino P; Coppock DL
Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
[TBL] [Abstract][Full Text] [Related]
5. Ethanol metabolism results in a G2/M cell-cycle arrest in recombinant Hep G2 cells.
Clemens DL; Calisto LE; Sorrell MF; Tuma DJ
Hepatology; 2003 Aug; 38(2):385-93. PubMed ID: 12883482
[TBL] [Abstract][Full Text] [Related]
6. Disruption of insulin-like growth factor-1 signaling and down-regulation of cdc2 by SC-alphaalphadelta9, a novel small molecule antisignaling agent identified in a targeted array library.
Vogt A; Rice RL; Settineri CE; Yokokawa F; Yokokawa S; Wipf P; Lazo JS
J Pharmacol Exp Ther; 1998 Nov; 287(2):806-13. PubMed ID: 9808713
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of p185neu kinase activity and cellular transformation by co-expression of a truncated neu protein.
Qian X; O'Rourke DM; Zhao H; Greene MI
Oncogene; 1996 Nov; 13(10):2149-57. PubMed ID: 8950982
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase A regulates cell cycle progression of mouse fertilized eggs by means of MPF.
Yu B; Wang Y; Liu Y; Liu Y; Li X; Wu D; Zong Z; Zhang J; Yu D
Dev Dyn; 2005 Jan; 232(1):98-105. PubMed ID: 15580572
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor gene product APC is hyperphosphorylated during the M phase.
Bhattacharjee RN; Hamada F; Toyoshima K; Akiyama T
Biochem Biophys Res Commun; 1996 Mar; 220(1):192-5. PubMed ID: 8602842
[TBL] [Abstract][Full Text] [Related]
10. Double-stranded RNA-dependent protein kinase, PKR, down-regulates CDC2/cyclin B1 and induces apoptosis in non-transformed but not in v-mos transformed cells.
Dagon Y; Dovrat S; Vilchik S; Hacohen D; Shlomo G; Sredni B; Salzberg S; Nir U
Oncogene; 2001 Dec; 20(56):8045-56. PubMed ID: 11781817
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cell-cycle regulatory signaling network by 2-methoxyestradiol in prostate cancer cells is mediated through multiple signal transduction pathways.
Ray G; Dhar G; Van Veldhuizen PJ; Banerjee S; Saxena NK; Sengupta K; Banerjee SK
Biochemistry; 2006 Mar; 45(11):3703-13. PubMed ID: 16533053
[TBL] [Abstract][Full Text] [Related]
12. Autographa californica nucleopolyhedrovirus infection results in Sf9 cell cycle arrest at G2/M phase.
Braunagel SC; Parr R; Belyavskyi M; Summers MD
Virology; 1998 Apr; 244(1):195-211. PubMed ID: 9581791
[TBL] [Abstract][Full Text] [Related]
13. A link between MAP kinase and p34(cdc2)/cyclin B during oocyte maturation: p90(rsk) phosphorylates and inactivates the p34(cdc2) inhibitory kinase Myt1.
Palmer A; Gavin AC; Nebreda AR
EMBO J; 1998 Sep; 17(17):5037-47. PubMed ID: 9724639
[TBL] [Abstract][Full Text] [Related]
14. Viral infections and cell cycle G2/M regulation.
Zhao RY; Elder RT
Cell Res; 2005 Mar; 15(3):143-9. PubMed ID: 15780175
[TBL] [Abstract][Full Text] [Related]
15. Identification of p185neu sequences required for monoclonal antibody- or ligand-mediated receptor signal attenuation.
Qian X; O'Rourke DM; Drebin J; Zhao H; Wang Q; Greene MI
DNA Cell Biol; 1997 Dec; 16(12):1395-405. PubMed ID: 9428788
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation sensitivity of the commonly used anti-p185neu/erbB2 monoclonal antibody clone 3B5 suggests selective usage of autophosphorylation sites.
DiGiovanna MP
Anal Biochem; 1997 Apr; 247(1):167-70. PubMed ID: 9126388
[No Abstract] [Full Text] [Related]
17. Impact of HER2 codon 655 polymorphism and expression of HER2 and HER3 in non small cell lung cancer patients.
Ananiev J; Aleksandrova E; Skerleva D; Gulubova M; Chokoeva A; Lotti T; Wollina U; Tchernev G; Kontić M; Stojšić J
Wien Med Wochenschr; 2015 Aug; 165(15-16):315-21. PubMed ID: 26208475
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of HER2/neu expression in gastric cancer.
Ananiev J; Gulubova M; Manolova I; Tchernev G
Wien Klin Wochenschr; 2011 Jul; 123(13-14):450-4. PubMed ID: 21739203
[TBL] [Abstract][Full Text] [Related]
19. Involvement of cdc2-mediated phosphorylation in the cell cycle-dependent regulation of p185neu.
Kiyokawa N; Karunagaran D; Lee EK; Xie Y; Yan DH; Hung MC
Oncogene; 1997 Nov; 15(22):2633-41. PubMed ID: 9400990
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
